ARCHIVES

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

NIH Seeking Nominations for Review Committees

February 23, 1979

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997

In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists

January 6, 1978

NCI Budget for FY 1977 Would Halt New Research

January 23, 1976

Northwestern, Rochester, Howard First In Line For Limited Construction Funds

August 20, 1976